Viatris Inc

Viatris Inc VTRS

Dividend Summary

The next Viatris Inc dividend will go ex in 5 days for 12c and will be paid in 29 days.
The previous Viatris Inc dividend was 12c and it went ex 3 months ago and it was paid 2 months ago.
There are typically 4 dividends per year (excluding specials).

Latest Dividends
Summary Previous dividend Next dividend
Status Paid Declared
Type Quarterly Quarterly
Per share 12c 12c
Declaration date 05 May 2022 (Thu) 04 Aug 2022 (Thu)
Ex-div date 23 May 2022 (Mon) 23 Aug 2022 (Tue)
Pay date 16 Jun 2022 (Thu) 16 Sep 2022 (Fri)

Enter the number of Viatris Inc shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
96%
Our premium tools have predicted Viatris Inc with 96% accuracy.
Dividend Yield Today
4.6%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Viatris Inc
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Forecast Quarterly 04 Feb 2027 11 Feb 2027 18 Mar 2027 USD Sign up
Forecast Quarterly 04 Nov 2026 12 Nov 2026 18 Dec 2026 USD Sign up
Forecast Quarterly 30 Jul 2026 18 Aug 2026 11 Sep 2026 USD Sign up
Forecast Quarterly 30 Apr 2026 18 May 2026 11 Jun 2026 USD Sign up
Forecast Quarterly 05 Feb 2026 12 Feb 2026 19 Mar 2026 USD Sign up
Forecast Quarterly 05 Nov 2025 13 Nov 2025 19 Dec 2025 USD Sign up
Forecast Quarterly 31 Jul 2025 19 Aug 2025 12 Sep 2025 USD Sign up
Forecast Quarterly 01 May 2025 19 May 2025 12 Jun 2025 USD Sign up
Forecast Quarterly 06 Feb 2025 13 Feb 2025 20 Mar 2025 USD Sign up
Forecast Quarterly 06 Nov 2024 14 Nov 2024 20 Dec 2024 USD Sign up
Forecast Quarterly 01 Aug 2024 20 Aug 2024 13 Sep 2024 USD Sign up
Forecast Quarterly 02 May 2024 20 May 2024 13 Jun 2024 USD Sign up
Forecast Quarterly 08 Feb 2024 15 Feb 2024 21 Mar 2024 USD Sign up
Forecast Quarterly 08 Nov 2023 16 Nov 2023 22 Dec 2023 USD Sign up
Forecast Quarterly 03 Aug 2023 22 Aug 2023 15 Sep 2023 USD Sign up
Forecast Quarterly 04 May 2023 22 May 2023 15 Jun 2023 USD Sign up
Forecast Quarterly 09 Feb 2023 16 Feb 2023 23 Mar 2023 USD Sign up
Forecast Quarterly 09 Nov 2022 17 Nov 2022 23 Dec 2022 USD Sign up
Declared Quarterly 04 Aug 2022 23 Aug 2022 16 Sep 2022 USD 12c 12c 😄
Paid Quarterly 05 May 2022 23 May 2022 16 Jun 2022 USD 12c 12c 😄
Paid Quarterly 06 Jan 2022 23 Feb 2022 16 Mar 2022 USD 11c 12c 😊
Paid Quarterly 08 Nov 2021 22 Nov 2021 16 Dec 2021 USD 11c 11c 😄
Paid Quarterly 09 Aug 2021 23 Aug 2021 16 Sep 2021 USD 11c 11c 😄
Paid Quarterly 10 May 2021 21 May 2021 16 Jun 2021 USD 11c
Year Amount Change
2006 0.0c
2007 0.0c
0%
2008 0.0c
0%
2009 0.0c
0%
2010 0.0c
0%
2011 0.0c
0%
2012 0.0c
0%
2013 0.0c
0%
2014 0.0c
0%
2015 0.0c
0%
2016 0.0c
0%
2017 0.0c
0%
2018 0.0c
0%
2019 0.0c
0%
2020 0.0c
0%
2021 45.0c
100%
2022 Sign Up Required
2023 Sign Up Required
2024 Sign Up Required
2025 Sign Up Required
2026 Sign Up Required

Viatris Inc Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
4.6%
Optimized Yield
Sign Up Required
52 Week High
7.2% on 07 August 2022
52 Week Low
3.0% on 23 August 2021
Next Ex-Div-Date Countdown
Sign Up Required

About Viatris Inc

Viatris Inc. is a global healthcare company. The Company has four segments: Developed Markets, Greater China, JANZ and Emerging Markets. Developed Markets segment comprises its operations primarily in North America and Europe. Greater China segment includes its operations in China, Taiwan and Hong Kong. JANZ segment reflects its operations in Japan, Australia and New Zealand. Emerging Markets segment encompasses its presence in approximately 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East, as well as its anti-retroviral franchise. Its portfolio comprises approximately 1,400 approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands, generics, complex generics, and biosimilars. It operates approximately 40 manufacturing sites worldwide, which produces oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients.

Sector
Pharmaceuticals & Biotechnology
Country
United States
Share Price
$10.75 (yesterday's closing price)
Shares in Issue
1,210 million
Market Cap
$13.0bn
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
1
Market Indices
S&P 500
No articles found